news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

[Introduction] Guizhou Sanli and Yinli Media are both expected to be targeted!

China Fund News reporter heard

On the evening of August 12, Guizhou Sanli announced that the controlling shareholder and actual controller Zhang Hai intends to transfer his 5.1244% stake in the company to Hainan Yuexin Pharmaceutical Investment Partnership (General Partnership) (hereinafter referred to as Yuexin Pharmaceutical) by agreement, with a total transfer price of 221 million yuan.

On the same evening, Gravity Media announced that Jiang Li, the controlling shareholder's joint actor, planned to transfer 5.60% of the company's shares held by her to Shanghai Quanqiao Private Equity Fund Management Co., Ltd. (hereinafter referred to as Quanqiao Fund) by agreement, with a total transfer price of 161.4 million yuan.

Two A-share companies were listed at a discount

Guizhou Sanli announced that Zhang Hai and Yuexin Pharmaceutical signed a "Share Transfer Agreement" on August 11. Zhang Hai intends to transfer his 21 million shares of the company's unrestricted tradable shares to Yuexin Pharmaceutical at a price of 10.50 yuan per share, with a total transfer price of 221 million yuan.

The shares to be transferred under the agreement account for 5.1244% of Guizhou Sanli's total share capital. Guizhou Sanli announced that after the transfer of the above shares, Yuexin Pharmaceutical will become a shareholder holding more than 5% of the company's shares.

As of the close of August 12, Guizhou Sanli's share price was 12.36 yuan per share, with a total market value of 5.065 billion yuan. That is, the discount rate of the above transaction was 15.05%.

On August 12, Jiang Li and Quanqiao Fund signed a "Share Transfer Agreement" stipulating that Jiang Li intends to transfer her 15 million shares of Gravity Media's unrestricted tradable shares to Quanqiao Fund at a price of 10.76 yuan per share, with a total transfer price of 161.4 million yuan.

The shares to be transferred account for 5.6% of the total share capital of Gravity Media. Gravity Media announced that if the transaction is finally completed, Quanqiao Fund will become a shareholder of the company with a shareholding of more than 5%.

As of the close of August 12, the share price of Gravity Media was 11.91 yuan per share, with a total market value of 3.19 billion yuan. That is, the discount rate of the above transaction was 9.62%.

Optimistic about the development prospects of the target company

Yuexin Pharmaceutical and Quanqiao Fund are planning to acquire shares in listed companies, and both mentioned that they are optimistic about the future development prospects of the target companies.

Guizhou Sanli is mainly engaged in drug research and development, production and sales. Its main products include Kaihoujian Spray, Qijiao Shengbai Capsules, Fuke Zaizao Pills, etc. Its performance in 2023 increased significantly year-on-year, but its performance in the first quarter of 2024 increased slightly year-on-year.

Yuexin Pharmaceutical was established on January 23, 2024. Its business scope includes investment activities with its own funds, medical research and experimental development, and traditional Chinese medicine clinic services (business activities can only be carried out after filing with the competent authority of traditional Chinese medicine).

Gravity Media is a digital marketing service company driven by content creativity and technological innovation. Its performance in 2023 increased significantly year-on-year, but its net profit attributable to shareholders of the parent company in the first quarter of 2024 decreased by 7.29% year-on-year, and its net profit after deducting non-recurring items increased by 21.82% year-on-year.

Quanqiao Fund was established on April 17, 2014. Its business scope includes private securities investment fund management services (it must complete registration and filing with the Asset Management Association of China before it can engage in business activities).

Capital demand + optimization of shareholder structure

When investigating the transferor's purpose of transferring shares, Zhang Hai said that it was to optimize the shareholder structure of Guizhou Sanli.

Guizhou Sanli announced that after the completion of the above transaction, Zhang Hai’s shareholding in the company will be 40.9145%, and Zhang Hai and his associates will hold a total of 46.6118% of the company’s shares.

However, due to personal financial needs, Zhang Hai and his joint actor Wang Huiying plan to reduce their holdings of the company's shares by no more than 3% from August 30 to November 29 through centralized bidding transactions and block transactions.

As of August 12, Zhang Hai’s shares in Guizhou Sanli accounted for 46.0389% of the total share capital, and the cumulative number of pledged shares accounted for 22.97% of the total share capital.

In contrast, Jiang Li plans to sell part of Gravity Media's shares. In addition to mentioning the optimization of the listed company's shareholder structure, she also mentioned that the listed company's controlling shareholder has an urgent desire to further reduce personal debt.

According to Gravity Media, Luo Yanji is the company's controlling shareholder, Jiang Li is Luo Yanji's spouse, and Beijing Hechuang Shengshi Management Consulting Partnership (Limited Partnership) is a partnership established with joint capital contributions from Luo Yanji and Jiang Li.

It is reported that from September 2022 to July 2023, Luo Yanji sold part of Gravity Media's shares to repay personal debts and reduce the pledge ratio.

According to the latest announcement from Gravity Media, the pledge ratio of the company's shares held by Luo Yanji and persons acting in concert has been reduced from 46.93% before the reduction in September 2022 to the current 25.74%.

Editor: Captain

Review: Chen Mo

Copyright Notice

"China Fund News" enjoys the copyright to the original content published on this platform. Reproduction without authorization is prohibited, otherwise legal liability will be pursued.

Contact person for authorized reprint cooperation: Mr. Yu (Tel: 0755-82468670)